Persistence of Immunity Following 2-Dose Priming with a 10-Valent Pneumococcal Conjugate Vaccine at 6 and 10 Weeks or 6 and 14 Weeks of Age in Nepalese Toddlers.
Gurung M. et al, (2021), Pediatr Infect Dis J
Should we be vaccinating children against COVID-19 in high-income countries?
Li G. et al, (2021), Expert Rev Vaccines, 1 - 4
CoronaVac: more data for regulators and policy makers.
Ramasamy MN. and Jessop LJ., (2021), Lancet, 398, 186 - 188
Comparison of the Immunogenicity of BNT162b2 and CoronaVac COVID-19 Vaccines in Hong Kong: An Observational Cohort Study
Mok CKP. et al, (2021), SSRN Electronic Journal
The role of interspecies recombination in the evolution of antibiotic-resistant pneumococci.
D'Aeth JC. et al, (2021), Elife, 10
"Should children be offered covid-19 vaccination?" No
Wilkinson D. et al, (2021), BMJ: British Medical Journal
Symptom study app provides real-world data on COVID-19 vaccines.
Drury RE. and O'Connor D., (2021), Lancet Infect Dis, 21, 890 - 891
Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against COVID-19: COVAC1, a Phase I, Dose-Ranging Trial
Pollock KM. et al, (2021), SSRN Electronic Journal
ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates - Authors' reply.
Voysey M. and Pollard AJ., (2021), Lancet, 397
SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties.
Oliu-Barton M. et al, (2021), Lancet, 397, 2234 - 2236
Charting mandatory childhood vaccination policies worldwide.
Vanderslott S. and Marks T., (2021), Vaccine